Blood and tissue study in high-risk sarcoma
Treatments studied
Part of Cancer clinical trials.
This study collects blood and tissue samples from people with high-risk soft tissue sarcoma before their surgery. The goal is to learn how the immune system responds to pre-surgery treatments like radiation and hyperthermia (heat therapy).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or are suspected to have a high-risk soft tissue sarcoma.
- You will have a surgical biopsy to confirm the diagnosis.
- You are scheduled to receive pre-surgery treatment (such as radiation and hyperthermia, with or without chemotherapy).
- You are 18 years or older and able to give informed consent.
- For the imaging part of the study, your treatment must be done using a special combined MRI-hyperthermia machine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
This trial tests a new approach for high-risk soft tissue sarcoma of the arm, leg, or trunk. Before surgery, you would receive chemotherapy combined with local hyperthermia (a treatment that gently heats the tumor area) to see if this can improve outcomes.
This study checks if a blood test can detect DNA from soft tissue sarcomas. The goal is to see if circulating tumor DNA can help doctors monitor the disease and plan treatment.
This study tests whether giving radiation, chemotherapy, and immunotherapy together can control high-risk soft tissue sarcoma that is hard to remove or may come back after surgery. It may help by attacking cancer in different ways, including boosting the immune system.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
This trial tests a new blood-test technology to find and study cancer cells in people with advanced soft tissue sarcoma. It aims to improve how we track the disease and guide treatment decisions.
Hear when a new Soft Tissue Sarcoma Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.